MEF2B and astrocytoma (excluding glioblastoma): MEF2BNB-MEF2B fusion was found to be prevalent in various cancers such as astrocytoma, cancer of unknown primary, NOS (not otherwise specified), esophagogastric carcinoma, meningioma, and mycosis fungoides in AACR Project GENIE cases [55].